Valsartan improves adipose tissue function in humans with impaired glucose metabolism: a randomized placebo-controlled double-blind trial.

Although the change in insulin sensitivity after VAL treatment was of the same order of magnitude (∼10%) in the subset of subjects that was studied here ( n = 38) compared with the total study population ( n = 79), the VAL-induced increase in insulin sensitivity did not reach statistical significance in the present analysis ( P = 0.248; Table 1 ).

also in 111,027 other papers